Daylife Select
A point & click tool to create dynamic content portals. Learn More »
Editor's Picks
There is no pinned content in this Editor's Picks module.
Click here to learn more about content pinning.
-
Improving and rationalizing this costly and dysfunctional system is a gigantic, maybe impossible, task. Full Article at ScienceBlogs
-
Scientists say the U.S. Food and Drug Administration is taking just as long as ever to approve new drugs, despite increased use of information technology. Full Article at The Post Chronicle
-
WASHINGTON - SEPTEMBER 29: (L-R) Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy, Drug Enforcement Administration Deputy Assistant Administrator Joseph Rannazzisi, United... View Photo »
-
The United States has decided against using adjuvants because the Food and Drug Administration has not fully reviewed them. Officials worried that a new product would make people even more nervous about the inoculation.
SOURCE: GroundReport -
In a case of something written into the 2008 farm bill thats yet to be enacted, U.S. catfish producers are pointing at the USDAs failure to inspect seafood imports. Full Article at Delta Farm Press
-
A joint public meeting focused on improving the system for tracing of food products and ingredients that are causing illness outbreaks or presenting other risks to the health of consumers was announced today by the Food and Drug Administration (FDA) of... Full Article at Broadcasting & Cable
-
The Food and Drug Administration is keeping a close watch on drug companies so that they don't cross federal marketing restrictions. These restrictions currently don't allow drug companies to participate in online social sites. Full Article at Associated Content
-
WASHINGTON - SEPTEMBER 29: Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy testifies before the Senate Judiciary Committee's Crime and Drugs Subcommittee during a hearing... View Photo »
-
Manufacturers urgently need a way to discuss end-to-end product development plans with the FDA (U.S. Food and Drug Administration) or its advisory boards early in the product development process
SOURCE: International Business Times -
-
Main Category: Endocrinology Also Included In: Medical Devices / Diagnostics Article Date: 25 Nov 2009 - 3:00 PST email to a friend printer friendly view / write opinions rate article Tulane University School of Medicine surgeon Dr. Emad... Full Article at Medical News Today
-
WASHINGTON, Nov. 25 (UPI) -- The U.S. Food and Drug Administration says it is seeking court action against a Louisiana seafood company because of alleged health safety violations. Full Article at United Press International
About Food and Drug Administration
Wikipedia
The U.S. Food and Drug Administration (FDA) is an agency of the United States Department of Health and Human Services and is responsible for the safety regulation of most types of foods, dietary supplements, drugs, vaccines, biological medical products, blood products, medical devices, radiation-emitting devices, veterinary products, and cosmeti... Full Article
Related Photos
prev
next
-
Getty Images
WASHINGTON - SEPTEMBER 29: (L-R) Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy, Drug Enforcement Administration Deputy Assistant Administrator Joseph Rannazzisi, United States Anti Doping Agency CEO Tra...
View Photo » -
Getty Images
WASHINGTON - SEPTEMBER 29: Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy testifies before the Senate Judiciary Committee's Crime and Drugs Subcommittee during a hearing on 'Body Building Products and Hi...
View Photo » -
Getty Images
WASHINGTON - SEPTEMBER 29: Deputy commissioner of the Food and Drug Administration Jesse Goodman testifies before the House Oversight and Government Reform Committee September 29, 2009 in Washington, DC.
View Photo » -
AP Photo
Michael Levy, director of the Food and Drug Administration's (FDA) division of new drugs and labeling compliance, testifies on Capitol Hill in Washington, Tuesday, Sept. 29, 2009, before a Senate Judiciary subcommittee hearing on dietary supplements.
View Photo » -
AP Photo
FILE - In this May 7, 2009 file photo, Food and Drug Administration Commissioner Margaret Hamburg testifies on Capitol Hill in Washington.
View Photo » -
AP Photo
The FDA has approved ONGLYZA(TM) (saxagliptin).
View Photo » -
AP Photo
FDA Approves Constar's new DiamondClear(R) Technology for PET Containers.
View Photo » -
AP Photo
FILE - In this May 7, 2009, file photo, Food and Drug Administration Commissioner-designate Margaret Hamburg speaks at confirmation hearing on Capitol Hill in Washington.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg arrives for her confirmation hearing before the Senate Health, Education, Labor and Pension Committee hearing, Thursday, May 7, 2009, on Capitol Hill in Washington.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg smiles as she testifies on Capitol Hill in Washington, Thursday, May 7, 2009, during the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing on her nomination.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg arrives for her confirmation hearing before the Senate Health, Education, Labor and Pension Committee hearing, Thursday, May 7, 2009, on Capitol Hill in Washington.
View Photo » -
AP Photo
Food and Drug Administration Commissioner-designate Margaret Hamburg testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before the Senate Health, Education, Labor and Pension Committee hearing, on her nomination.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, Agricultural Secretary Tom Vilsack, center, testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, accompanied by Agricultural Secretary Tom Vilsack, center, testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, Agricultural Secretary Tom Vilsack, center, testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein testifies on Capitol Hill in Washington, Thursday, May 7, 2009, before a Senate Appropriations subcommittee hearing on the swine flu.
View Photo » -
Getty Images
WASHINGTON - APRIL 30: Acting Commissioner of Food and Drug Administration Joshua Sharfstein (L) speaks as Interim Deputy Director of Science and Public Health Program Rear Admiral Anne Schuchat of the Centers for Disease Control and Prevention looks on during a hearing before the Heal...
View Photo » -
Getty Images
WASHINGTON - APRIL 30: (L-R) Acting Commissioner of Food and Drug Administration Joshua Sharfstein, Interim Deputy Director of Science and Public Health Program Rear Admiral Anne Schuchat of the Centers for Disease Control and Prevention, and Assistant Health and Human Services Secreta...
View Photo » -
Getty Images
WASHINGTON - APRIL 30: Acting Commissioner of Food and Drug Administration Joshua Sharfstein speaks during a hearing before the Health Subcommittee of the House Committee on Energy and Commerce April 30, 2009 on Capitol Hill in Washington, DC.
View Photo » -
Getty Images
WASHINGTON - APRIL 30: (L-R) Acting Commissioner of Food and Drug Administration Joshua Sharfstein, Interim Deputy Director of Science and Public Health Program Rear Admiral Anne Schuchat of the Centers for Disease Control and Prevention, and Assistant Health and Human Services Secretar...
View Photo » -
AP Photo
FDA Commissioner Joshua Sharfstein, left, and Rear Admiral Anne Schuchat of the Center for Disease Control and Prevention arrive for a House Energy and Commerce Committee hearing on swine flu on Thursday, April 30, 2009 in Washington.
View Photo »
Getty Images
WASHINGTON - SEPTEMBER 29: Office of Compliance of the Food and Drug Administration's Center for Drug Evaluation and Research Division Director Michael Levy testifies before the Senate Judiciary Committee's Crime and Drugs Subcommittee during a hearing on 'Body Building Products and Hi...
View Photo »
